Digital Biomarkers of Social Anxiety Severity: Digital Phenotyping Using Passive Smartphone Sensors.

biomarkers machine learning mobile phone social anxiety social anxiety disorder technology assessment, biomedical

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
29 05 2020
Historique:
received: 04 11 2019
accepted: 27 02 2020
revised: 26 02 2020
pubmed: 30 4 2020
medline: 20 11 2020
entrez: 30 4 2020
Statut: epublish

Résumé

Social anxiety disorder is a highly prevalent and burdensome condition. Persons with social anxiety frequently avoid seeking physician support and rarely receive treatment. Social anxiety symptoms are frequently underreported and underrecognized, creating a barrier to the accurate assessment of these symptoms. Consequently, more research is needed to identify passive biomarkers of social anxiety symptom severity. Digital phenotyping, the use of passive sensor data to inform health care decisions, offers a possible method of addressing this assessment barrier. This study aims to determine whether passive sensor data acquired from smartphone data can accurately predict social anxiety symptom severity using a publicly available dataset. In this study, participants (n=59) completed self-report assessments of their social anxiety symptom severity, depressive symptom severity, positive affect, and negative affect. Next, participants installed an app, which passively collected data about their movement (accelerometers) and social contact (incoming and outgoing calls and texts) over 2 weeks. Afterward, these passive sensor data were used to form digital biomarkers, which were paired with machine learning models to predict participants' social anxiety symptom severity. The results suggested that these passive sensor data could be utilized to accurately predict participants' social anxiety symptom severity (r=0.702 between predicted and observed symptom severity) and demonstrated discriminant validity between depression, negative affect, and positive affect. These results suggest that smartphone sensor data may be utilized to accurately detect social anxiety symptom severity and discriminate social anxiety symptom severity from depressive symptoms, negative affect, and positive affect.

Sections du résumé

BACKGROUND
Social anxiety disorder is a highly prevalent and burdensome condition. Persons with social anxiety frequently avoid seeking physician support and rarely receive treatment. Social anxiety symptoms are frequently underreported and underrecognized, creating a barrier to the accurate assessment of these symptoms. Consequently, more research is needed to identify passive biomarkers of social anxiety symptom severity. Digital phenotyping, the use of passive sensor data to inform health care decisions, offers a possible method of addressing this assessment barrier.
OBJECTIVE
This study aims to determine whether passive sensor data acquired from smartphone data can accurately predict social anxiety symptom severity using a publicly available dataset.
METHODS
In this study, participants (n=59) completed self-report assessments of their social anxiety symptom severity, depressive symptom severity, positive affect, and negative affect. Next, participants installed an app, which passively collected data about their movement (accelerometers) and social contact (incoming and outgoing calls and texts) over 2 weeks. Afterward, these passive sensor data were used to form digital biomarkers, which were paired with machine learning models to predict participants' social anxiety symptom severity.
RESULTS
The results suggested that these passive sensor data could be utilized to accurately predict participants' social anxiety symptom severity (r=0.702 between predicted and observed symptom severity) and demonstrated discriminant validity between depression, negative affect, and positive affect.
CONCLUSIONS
These results suggest that smartphone sensor data may be utilized to accurately detect social anxiety symptom severity and discriminate social anxiety symptom severity from depressive symptoms, negative affect, and positive affect.

Identifiants

pubmed: 32348284
pii: v22i5e16875
doi: 10.2196/16875
pmc: PMC7293055
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16875

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA029926
Pays : United States

Informations de copyright

©Nicholas C Jacobson, Berta Summers, Sabine Wilhelm. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 29.05.2020.

Références

J Biomed Inform. 2018 Jan;77:120-132
pubmed: 29248628
Behav Res Ther. 2000 Sep;38(9):943-50
pubmed: 10957828
J Anxiety Disord. 2017 Oct;51:39-46
pubmed: 28922648
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
J Med Internet Res. 2011 Aug 12;13(3):e55
pubmed: 21840837
Cyberpsychol Behav. 2007 Jun;10(3):424-35
pubmed: 17594267
Arch Gen Psychiatry. 2008 Dec;65(12):1429-37
pubmed: 19047530
J Affect Disord. 2016 Dec;206:48-54
pubmed: 27466742
JMIR Ment Health. 2018 Jul 04;5(3):e10101
pubmed: 29973337
NPJ Digit Med. 2019 Feb 1;2:3
pubmed: 31304353
J Med Internet Res. 2017 Mar 03;19(3):e62
pubmed: 28258049
Psychol Med. 1999 May;29(3):555-67
pubmed: 10405077
Psychol Med. 1999 Jan;29(1):199-212
pubmed: 10077308
Eur Psychiatry. 2000 Feb;15(1):5-16
pubmed: 10713797
J Nerv Ment Dis. 2019 Oct;207(10):893-896
pubmed: 31596769
Behav Res Methods. 2019 Feb;51(1):295-315
pubmed: 30120682
J Med Internet Res. 2017 Jul 24;19(7):e262
pubmed: 28739561
JMIR Ment Health. 2019 Feb 20;6(2):e9819
pubmed: 30785404
PeerJ. 2016 Jul 12;4:e2197
pubmed: 27478700
Br J Psychiatry. 2019 Jul 12;:1-3
pubmed: 31298167
Psychiatry Res. 2011 May 30;187(3):375-81
pubmed: 21310497
Psychol Med. 2008 Jan;38(1):15-28
pubmed: 17976249
Soc Psychiatry Psychiatr Epidemiol. 1999 Aug;34(8):416-24
pubmed: 10501711
Behav Res Ther. 1998 Apr;36(4):455-70
pubmed: 9670605
Br J Clin Psychol. 2003 Jun;42(Pt 2):111-31
pubmed: 12828802
Psychol Bull. 2017 Nov;143(11):1155-1200
pubmed: 28805400
Pers Soc Psychol Bull. 2013 Oct;39(10):1359-72
pubmed: 23798373
Behav Ther. 2020 Jan;51(1):1-14
pubmed: 32005328
Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84
pubmed: 22865617
J Neuroeng Rehabil. 2009 Aug 05;6:32
pubmed: 19656364

Auteurs

Nicholas C Jacobson (NC)

Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.

Berta Summers (B)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Sabine Wilhelm (S)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH